(NYSE MKT: VTAK), FORT MILL, S.C., Sept. 30, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced that it has received notification from the United States Patent and Trademark Office of the allowance for issuance […]

RANCHO SANTA MARGARITA, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) — In today's data-driven business landscape, inaccurate data causes more business risk than just IT problems. Melissa's new research study, The State of Enterprise Data Quality 2025, finds 84% of organizations struggle with inaccurate or duplicate data, causing direct impact on operations, compliance, and customer experience.

(NasdaqGM:SCYX), No safety concerns or dose limiting toxicities observed SCY-247 was able to achieve target exposures at doses lower than our first-generation fungerp Safety, tolerability, and pharmacokinetic profile support the continued clinical development of SCY-247 JERSEY CITY, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to

(NASDAQ:CRNC), SUMMARY AND KEY POINTS: Suzuki Motor Corporation and Cerence AI are collaborating to build an in-car assistant for Suzuki's e VITARA model. Suzuki will be the first Japanese automaker to bring a Cerence Assistant-powered experience to market in Japan, building on Cerence's robust in-market footprint. The announcement further solidifies Cerence's position as a conversational

BOSTON, Sept. 30, 2025 (GLOBE NEWSWIRE) — Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, and its clinical development division, Sardocor, today announced the appointments of three senior executives to strengthen its leadership team. The expanded team includes Fubao Wang, Ph.D., as Chief Regulatory Officer and Chief

(NASDAQ:ECOR), ROCKAWAY, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a peer-reviewed study in Frontiers in Neurology demonstrating the effectiveness of gammaCore(R) non-invasive vagus nerve stimulation (nVNS) in reducing persistent symptoms associated with mild traumatic brain injury (mTBI). “The CDC

ORLANDO, Fla., Sept. 30, 2025 (GLOBE NEWSWIRE) — AssistRx, the advanced therapy initiation and patient solutions provider, today announced its participation in the second annual Drug Channels Leadership Forum as a Diamond Sponsor. Hosted by the Drug Channels Institute (DCI), an HMP Global company, the event will be held March 16-18, 2026, at the Turnberry

SUNNYVALE, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) — Real-Time Innovations (RTI), the software framework company for physical AI systems, will host a live webinar titled Engineering Telesurgery: A Collaborative Blueprint for Advanced Systems Integration on October 23, 2025, at 8:00 a.m. PDT. The 60-minute session will feature presentations and a panel discussion with experts from

RESTON, VA, Sept. 30, 2025 (GLOBE NEWSWIRE) — MedCerts, a leader in online healthcare and IT career training and a Stride Inc. portfolio company, today announced a landmark partnership with eHBCU, the nation's first digital HBCU consortium. This collaboration combines MedCerts' workforce development expertise with the cultural legacy of HBCUs to expand access to career-focused

ASP Isotopes Announces Purchase Order for Enriched Barium-137 from a U.S.-Based Customer GlobeNewswire September 30, 2025 WASHINGTON, Sept. 30, 2025 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries,